| abstract |
(57) [Summary] (Corrected) [PROBLEMS] To provide a drug which has excellent platelet aggregation inhibitory activity, has no side effects such as bleeding, and has high action selectivity. Further, the present invention provides a platelet aggregation inhibitor which is effective for vascular lesions such as vasospasm. SOLUTION: The compound represented by the following general formula (I) having a platelet aggregation inhibitory action, and a pharmacologically acceptable salt and solvate thereof. As a specific example of the compound, 2- [4- [1- (3- Pyridyloxy) -2- [4- (4-pyridyl) piperazinyl] ethyl] phenoxy] acetic acid. |